A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies.

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

ARLINGTON, Va., March 13, 2025 /PRNewswire-PRWeb/ -- The National Association of Chain Drug Stores (NACDS) today announced the promotion of Marilyn Hunter to vice president of meetings and conferences ...

C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

That includes keeping the historic heart of the town beating when new retail chains open in nearby housing estates. New homes being built in Kingsfield Estate, on the eastern edge of Sunbury ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. President Donald Trump’s first month in office has been dizzying for U.S ...

Are you looking for today’s ARI Wallet Daily Quiz Answer? The quiz question for February 27, 2025, is "What is the main advantage of the API provided by Arichain?". Staking in Arichain helps secure ...

Everything's coming up chicken. According to Restaurant Business Online, 20 chains launched a new version of the chicken sandwich on their menus, including fast-food juggernauts like McDonald's and ...

This performance exceeds recent expert consensus recommendations for an Alzheimer’s disease blood biomarker test to serve as a substitute for CSF or PET alternatives. C2N CEO Dr. Joel Braunstein says, ...

First Global Regulatory Approval of PrecivityAD2 for Use as an In-Vitro Diagnostic to Aid in the Diagnosis of Alzheimer’s Disease The PrecivityAD2 blood test is an analytically and clinically ...